期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Biomarkers in Medicine LetPub Score 6.3
50 ratings
Rate
Reputation 7.6 Influence 4.9 Speed 8.0 | ||||||||||||||||||||||||
期刊簡稱 | BIOMARK MED | ||||||||||||||||||||||||
ISSN | 1752-0363 | ||||||||||||||||||||||||
E-ISSN | 1752-0371 | ||||||||||||||||||||||||
h-index | 37 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 5.30%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://www.futuremedicine.com/loi/bmm | ||||||||||||||||||||||||
在線稿件提交 | http://www.futuremedicine.com/page/submitarticle | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Future Medicine Ltd. | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||||||
創刊年 | 2007 | ||||||||||||||||||||||||
每年文章數 | 83每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 10.80% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1752-0363%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Slow, 6-12 Week(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Ordinary | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
首頁 上一頁 1 2 3 下一頁 末頁 (頁 | |
[Biomarkers in Medicine] 的評論 | 撰寫評論 |
作者: 幽香思怡 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-13 13:23:32 評論於 Please translate the following paragraph into English and Japanese, and use ":" and "(0) 讚! | 幽香思怡 |
作者: 中原梓瑶 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-31 16:41:53 評論於 Could you please specify which direction exactly?(0) 讚! | 中原梓瑶 |
作者: 风神林帆 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-22 18:20:26 評論於 Choose subscription, no need for page charges if you do not select open access(0) 讚! | 风神林帆 |
作者: 风神林帆 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-09 19:30:18 評論於 First Trial 5 Months(0) 讚! | 风神林帆 |
作者: 法慧晴画 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-23 15:26:09 評論於 Are your figures uploaded as a zip file? Or are they uploaded individually as images?(0) 讚! | 法慧晴画 |
作者: 东风谷运华 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-12 20:25:35 評論於 How much is the usual layout fee?(0) 讚! | 东风谷运华 |
作者: 太山晓芳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-01 21:34:07 評論於 Has the status changed now?(0) 讚! | 太山晓芳 |
作者: 太山晓芳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-01 20:41:31 評論於 Has the current situation changed?(0) 讚! | 太山晓芳 |
作者: 风神林帆 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-02 13:24:46 評論於 Review speed: 6.0 Sharing experience: It has been a few months since submission, and it is still under consideration. I really want to know how long it takes for others to get their first review(0) 讚! | 风神林帆 |
作者: 东风谷运华 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-24 14:05:11 評論於 Research focus: Medical laboratory experience sharing: May I know the publication fee?(0) 讚! | 东风谷运华 |
作者: 菩提怡辰 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-30 12:18:14 評論於 Which citation format should I choose for this magazine article? Where can I download the dataset?(0) 讚! | 菩提怡辰 |
作者: 狮吼江胜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-15 10:47:43 評論於 Review speed: 6.0 | Submission hit rate: 5.0 Emphasized research direction: Oncology; Oncology experience sharing: High rejection rate(0) 讚! | 狮吼江胜 |
作者: 擒龙醉丝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-18 18:46:03 評論於 Hello, just wanted to check in and see how things are going now(0) 讚! | 擒龙醉丝 |
作者: 北陆翰翮 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-10-05 15:41:10 評論於 Hello, are you still there? I am four days late compared to you(0) 讚! | 北陆翰翮 |
作者: 北陆翰翮 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-10-05 15:11:52 評論於 It's not an official account, why do you choose such an expensive page fee?(0) 讚! | 北陆翰翮 |
作者: Myron Obadiah 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-09-27 11:32:39 評論於 Submission quickly changed to Under Consideration after submission(0) 讚! | Myron Obadiah |
作者: 稻妻迎旋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-09-19 22:25:23 評論於 Hello, may I ask a question? It's been over ten days since I submitted my proposal, and it has always been in the status of just submitted. Based on your past experience, has it been reviewed? Or is it still in the hands of the editor and has not been reviewed yet? Should I send an email to the editor to remind them?(0) 讚! | 稻妻迎旋 |
作者: 稻妻迎旋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-09-19 21:16:31 評論於 May I ask when your article was last updated? How is the status of the article now, has it been accepted? What are the opinions given by the reviewers?(0) 讚! | 稻妻迎旋 |
作者: 稻妻迎旋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-09-19 19:14:04 評論於 Was your article accepted after it was submitted to another magazine?(0) 讚! | 稻妻迎旋 |
作者: 珉林喜春 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-09-03 15:38:26 評論於 Did you choose open access when you submitted? The publication fee is 3500?(0) 讚! | 珉林喜春 |
作者: 格拉迪斯桑代克 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-08-17 20:06:42 評論於 Is it also $3500 if I don't choose open access?(0) 讚! | 格拉迪斯桑代克 |
作者: 降龙慧君 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-08-13 17:05:19 評論於 Their submission to the magazine is usually under consideration for about two weeks. If revisions are needed, it will remain under consideration until accepted directly(0) 讚! | 降龙慧君 |
作者: 降龙慧君 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-08-10 13:34:01 評論於 Review speed: 2.0 | Submission acceptance rate: 95.0 | Page fees: 3500.0 Emphasized research direction: Oncology; Clinical trial sharing experience: The article is clinically inclined towards esophageal cancer. The review took one month for minor revisions, and it was accepted one month after revisions. Overall, it was relatively fast, with page fees of $3500. One thing to note is that their system does not provide proof immediately after acceptance; an editor's letter is needed, which generally gets a response within two days. When submitting, there's no option to choose first or corresponding authorship, it must be indicated on the title page(0) 讚! | 降龙慧君 |
作者: 格拉迪斯桑代克 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-08-10 09:53:02 評論於 I remember that it seems like I turned into under review in two or three weeks(0) 讚! | 格拉迪斯桑代克 |
作者: 血天叶农 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-07-31 10:11:43 評論於 Hello, what is the process after submission of the contribution? Can you share it?(0) 讚! | 血天叶农 |
首頁 上一頁 1 2 3 下一頁 末頁 (頁 |
Contact us